O. Yazici Et Al. , "Role of glutamine for preventing oxaliplatin induced peripheral neuropathy (GELUPO): results of randomized open-label phase II trial," 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO) , vol.27, Copenhagen, Denmark, 2016
Yazici, O. Et Al. 2016. Role of glutamine for preventing oxaliplatin induced peripheral neuropathy (GELUPO): results of randomized open-label phase II trial. 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO) , (Copenhagen, Denmark).
Yazici, O., Titiz, A. P., Ozdemir, N., Aksoy, S., Sendur, M. A., Arli, B., ... Zengin, N.(2016). Role of glutamine for preventing oxaliplatin induced peripheral neuropathy (GELUPO): results of randomized open-label phase II trial . 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, Denmark
Yazici, O. Et Al. "Role of glutamine for preventing oxaliplatin induced peripheral neuropathy (GELUPO): results of randomized open-label phase II trial," 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, Denmark, 2016
Yazici, O. Et Al. "Role of glutamine for preventing oxaliplatin induced peripheral neuropathy (GELUPO): results of randomized open-label phase II trial." 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO) , Copenhagen, Denmark, 2016
Yazici, O. Et Al. (2016) . "Role of glutamine for preventing oxaliplatin induced peripheral neuropathy (GELUPO): results of randomized open-label phase II trial." 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO) , Copenhagen, Denmark.
@conferencepaper{conferencepaper, author={O. Yazici Et Al. }, title={Role of glutamine for preventing oxaliplatin induced peripheral neuropathy (GELUPO): results of randomized open-label phase II trial}, congress name={41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO)}, city={Copenhagen}, country={Denmark}, year={2016}}